Do you provide MITF regulation?
Measuring MITF regulation at gene and protein level
MITF sits at the centre of melanocyte biology. It controls survival and differentiation, and it drives transcription of tyrosinase, TYRP1 and DCT. A change in MITF therefore tends to move the whole pigment programme. The study measures that change and checks whether pigment production follows it.
Treatment and sampling
Human melanocytes are exposed to the test sample across a concentration range, with untreated, vehicle and reference controls. Samples are collected at more than one time point, because mRNA usually shifts before protein and melanin. Early points capture the transcript response, and later points capture the pigment that follows.
Molecular methods
Quantitative reverse-transcription PCR gives MITF mRNA relative to housekeeping genes. Western blotting measures protein abundance, and immunostaining shows whether MITF sits in the nucleus where it acts. Together these readings describe expression and localisation.
Linking MITF to pigment output
Downstream measurements tie the molecular result to function. The study typically reports:
- Tyrosinase and other target gene expression
- Cellular tyrosinase activity
- Melanin content per cell
- Viability and proliferation at each dose
A lower MITF paired with lower tyrosinase and melanin, at full viability, describes a coherent brightening mechanism. Higher values across the same markers support pigment-promoting research. For a broader cellular view, results can feed into melanocyte activity testing. The final report includes fold-change tables, blot images and the statistical comparison with controls.
When to order MITF regulation studies
Order this study when you need a named transcriptional mechanism for an active, or when a melanin screen has shown an effect and you want to know whether it starts at the gene level. MITF data is often paired with upstream signalling work for a full mechanism package, and it gives formulators a clear reason to choose one active over another.
Concentrations, reference compound and Western blot needs
Provide the sample, solvent and a concentration range that is non-toxic to melanocytes, if known. Say which direction of pigment change you are looking for and which reference compound you trust. Indicate whether you need protein data as well as mRNA, since Western blotting adds a further step.
Assessing molecular providers
Ask which housekeeping genes the laboratory uses and how it validates them in melanocytes. Check that time points are chosen for both transcript and protein. Providers that also offer alpha-MSH pathway regulation can show whether an MITF change follows from reduced upstream signalling, which makes the mechanism easier to present.
More in Pigmentation & Melanogenesis
Pigmentation & Melanogenesis testing studies how actives change melanin synthesis, melanocyte behaviour and pigment transfer in lab models.











